(Q54076978)

24 May 2018

title

A putative role for c-Fos in the pathophysiology of Paget's disease. (English)

1 reference

24 May 2018

1 reference

3

1 reference

24 May 2018

author name string

K E Beedles

series ordinal

1

1 reference

24 May 2018

P T Sharpe

series ordinal

2

1 reference

24 May 2018

A E Grigoriadis

series ordinal

4

1 reference

24 May 2018

publication date

1 October 1999

1 reference

24 May 2018

Journal of Bone and Mineral Research

published in

1 reference

24 May 2018

volume

14 Suppl 2

1 reference

24 May 2018

page(s)

21-28

1 reference

24 May 2018

Dogs, distemper and Paget's disease

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Genetic linkage of Paget disease of the bone to chromosome 18q

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Osteoblasts are target cells for transformation in c-fos transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Targeting simian virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Deregulated c-fos expression interferes with normal bone development in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

Bone and haematopoietic defects in mice lacking c-fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650140206

21 January 2018

Identifiers

DOI

10.1002/JBMR.5650140206

1 reference

24 May 2018

PubMed ID

10510209

1 reference

24 May 2018